Who are the key players in US External Ventricular Drain industry?

The top 5 players in the US External Ventricular Drain industry include Medtronic, Integra LifeSciences, B. Braun Melsungen AG, Spiegelberg, and Sophysa. These companies dominate the market with advanced technologies, strong market presence, significant R&D investment, and diversified product offerings catering to neurosurgical and critical care needs.

What is the US External Ventricular Drain growth?

The US External Ventricular Drain market is experiencing steady growth, driven by rising incidences of traumatic brain injury and neurological disorders. For example, Medtronic reported increased demand for its neurocritical care products in 2023, boosting market expansion and supporting improved patient management in acute healthcare settings.

Which segment accounted for the largest US External Ventricular Drain share?

Among applications, the traumatic brain injury segment accounted for the largest share of the US External Ventricular Drain market. This dominance is attributed to the high incidence of head injuries requiring cerebrospinal fluid management and the critical role of EVDs in treating increased intracranial pressure in emergency cases.

What are the factors driving the US External Ventricular Drain?

Major drivers include advancements in neurosurgical techniques and increased prevalence of neurological disorders. For example, Integra LifeSciences has introduced user-friendly, infection-resistant EVD systems to reduce complications and improve patient outcomes, reflecting the industry’s focus on technology enhancements and quality of care.

Which type accounted for the largest US External Ventricular Drain share?

Ventricular External Drainage Sets lead as the largest type in the US EVD market due to their versatile use, accuracy in monitoring intracranial pressure, and widespread adoption by hospitals for both adult and pediatric neurosurgical patients, ensuring effective cerebrospinal fluid drainage and reducing neurological complications.

Home Medical Devices

US External Ventricular Drain Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: US External Ventricular Drain
Brand: Bussiness Insights

US External Ventricular Drain Market: by Type (Standard EVD, Antibiotic-impregnated EVD, MRI-compatible EVD, Adjustable Pressure EVD, Integrated monitoring EVD, Other Types), Application (Hydrocephalus, Traumatic Brain Injury, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Meningitis, Other Applications), Distribution Channels (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Online Channels, Distributors, Others), Technology (Manual EVD Systems, Automated EVD Systems, Digital EVD Systems, Wireless EVD Systems, Smart EVD Systems, Conventional EVD Systems), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20153 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample

US External Ventricular Drain Market Outlook, Size, Share & Growth Analysis (2025-2035)

The US External Ventricular Drain (EVD) market represents a critical segment within the neurocritical care and neurosurgical device space. EVDs are vital for the temporary relief of intracranial pressure (ICP) due to conditions like hydrocephalus, hemorrhages, or traumatic brain injuries. The market encompasses a range of products including standard, antibiotic-impregnated, MRI-compatible, adjustable pressure, and integrated monitoring EVDs. Increasing neurological disease prevalence, rising trauma cases, technological advancements such as digital and smart EVD systems, and advancements in infection control are driving the market. Demand is primarily from hospitals, but ambulatory centers and specialty clinics are seeing fast growth. Competitive dynamics are shaped by innovation, regulatory compliance, and strategic partnerships. Major players include Medtronic, Integra LifeSciences, and Smiths Medical. Continuous R&D, enhanced safety features, and integration with health monitoring platforms are expected to provide new growth opportunities.

Latest Market Dynamics

Key Drivers

Integration of digital health technologies and remote pressure monitoring in EVD systems to optimize patient management. For instance, Natus Medical Incorporated introduced smart EVD devices with wireless capabilities, supporting real-time data collection and clinical decision-making.
Increased focus on infection prevention with antibiotic-impregnated and hydrogel-coated EVDs. Smiths Medical’s latest product lines showcase enhanced protection against device-related infections, aligning with current hospital infection control standards.

Expansion of EVD indications beyond traditional uses, such as in complex brain surgeries and acute neurological emergencies, opening new avenues for product adoption. Sophysa has expanded its product portfolio to address broader neurosurgical procedures, positioning for future volume growth.
Adoption of EVDs in ambulatory surgical centers and specialty clinics due to their minimally invasive nature and improved reimbursement policies. B. Braun Melsungen has recently partnered with outpatient facilities to facilitate widespread EVD utilization.

Risk of complications such as infections and catheter blockages continues to be a challenge, requiring ongoing product innovation. Spiegelberg GmbH & Co. KG is investing in research to develop EVDs with anti-clogging properties and improved infection resistance.
Training requirements for clinicians in using newer digital and smart EVD systems create an adoption barrier, especially in non-tertiary care centers. Dispomedica GmbH is collaborating with medical institutions to enhance user training and streamline adoption.

Stringent regulatory requirements and complex approval processes delay time-to-market for innovative EVD products. Möller Medical GmbH faced extended approval timelines for its MRI-compatible EVD range due to evolving FDA standards.
High procedural and device costs act as a restraint, particularly for smaller hospitals or clinics with limited budgets. G. SURGIWEAR LTD has highlighted the affordability challenge within smaller and rural health centers, spurring the need for cost-effective solutions.

The type-wise analysis reveals that standard EVDs command the largest market share, accounting for 40% of the US market in 2025. Antibiotic-impregnated EVDs have seen substantial uptake, reflecting 28% due to their efficacy in infection reduction. MRI-compatible EVDs account for 18%, driven by the rising number of neuroimaging procedures requiring device compatibility. Integrated monitoring and other advanced types together hold the remaining 14%. The increasing adoption of feature-rich and infection-resistant EVDs, alongside regulatory approvals of next-generation devices, is anticipated to further redistribute the type-wise market share in coming years.

Hydrocephalus is projected to account for the largest share at 42% of EVD applications in 2025, driven by its high treatment prevalence. Traumatic brain injury follows at 25%, supported by increased emergency neurosurgical procedures. Intracerebral hemorrhage and subarachnoid hemorrhage collectively represent 21% of applications as the use of EVDs expands in critical care. Meningitis and other applications account for 12%, reflecting growing awareness of EVD use in complex neurological infections. The dominance of hydrocephalus stems from its chronic management needs, but robust growth is anticipated among trauma and cerebrovascular indications.

The US External Ventricular Drain market revenue is expected to demonstrate steady growth from USD 290 Million in 2020 to nearly USD 490 Million by 2035. Key drivers fueling this upward trend include the rising burden of neurological diseases, increased adoption of technologically advanced EVD systems, and improved reimbursement policies. The most significant acceleration is forecasted between 2025 and 2030, where annual investments in digital and smart EVDs are anticipated to drive market expansion. The growing awareness among clinicians and improved clinical protocols for brain injuries also contribute to sustained revenue growth during the forecast period.

Year-over-year (YOY) growth in the US EVD market is expected to remain positive, averaging 4.2% between 2020 and 2025, and accelerating to around 5% between 2026 and 2030 due to rapid adoption of automated and smart EVD systems. Growth moderates slightly beyond 2030 as the market matures and penetration reaches established hospital networks. External factors like economic cycles and regulatory changes can lead to minor annual fluctuations. Sustained innovation and greater integration with hospital IT systems are key contributors to the market's healthy growth trajectory.

Regional segmentation shows that the Northeast holds the leading share of 38% in the US EVD market in 2025 due to concentration of top-tier hospitals and research institutes. The Midwest follows with 26%, reflecting strong penetration into academic medical centers. The South and West each contribute 19% and 17% respectively as both regions expand their specialty neurosurgical services and acute care capabilities. The robust demand in the Northeast is expected to drive continuous technological advancements, while growth in the South and West is supported by increasing access to advanced neurosurgical care.

Medtronic leads the US External Ventricular Drain market with a commanding 25% share in 2025, owing to its comprehensive product offerings and robust clinical partnerships. Integra LifeSciences secures a 19% share, leveraging recent technological innovations. Smiths Medical, with 16%, continues to strengthen its portfolio through digital and infection-resistant EVDs. The competitive landscape is shaped by continuous R&D investments, strategic collaborations, and expansion of advanced product lines. Remaining market share is distributed among other vendors focusing on niche applications and regional presence.

Hospitals remain the dominant buyers, accounting for 66% of the US EVD market in 2025, primarily due to the complexity of neurosurgical procedures and critical care infrastructure present in these settings. Ambulatory surgical centers contribute 18%, reflecting the growing adoption of minimally invasive and outpatient neurosurgical solutions. Specialty clinics take up 10%, while the remaining share is split among online channels and distributors. As outpatient neurosurgery becomes more prevalent, ambulatory centers are poised for accelerated share growth in the future.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	340
Regions	US regions (Northeast, Midwest, South, West)
Segments	Type (Standard EVD, Antibiotic-impregnated EVD, MRI-compatible EVD, Adjustable Pressure EVD, Integrated monitoring EVD, Other Types), Application (Hydrocephalus, Traumatic Brain Injury, Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Meningitis, Other Applications), Distribution Channels (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Online Channels, Distributors, Others), Technology (Manual EVD Systems, Automated EVD Systems, Digital EVD Systems, Wireless EVD Systems, Smart EVD Systems, Conventional EVD Systems), Organization Size (Small, Medium, Large)
Players	Medtronic, Integra LifeSciences, Spiegelberg GmbH & Co. KG, Sophysa, B. Braun Melsungen, Natus Medical Incorporated, Smiths Medical, Biometrix, Dispomedica GmbH, Möller Medical GmbH, G. SURGIWEAR LTD, PS Medical, Orsan Medical Technologies, Redax, Arkis Biosciences

June 2024: Medtronic launched a next-generation digital EVD system featuring real-time wireless monitoring capabilities for critical care units.
July 2024: Integra LifeSciences announced an exclusive partnership with major US neurosurgery centers to pilot their new antibiotic-impregnated EVD.
August 2024: Smiths Medical introduced a portfolio extension featuring integrated hydrogel coatings to combat catheter-associated infections.
September 2024: B. Braun Melsungen expanded its automated EVD distribution to prominent ambulatory surgical centers in the Midwest.
October 2024: Sophysa received FDA clearance for its adjustable pressure smart EVD system with enhanced remote calibration features.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Medical Devices. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

Medical DevicesMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

US External Ventricular Drain Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

US External Ventricular Drain Market Outlook, Size, Share & Growth Analysis (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

US External Ventricular Drain Market Share by Type, 2025

US External Ventricular Drain Market Share by Application, 2025

US External Ventricular Drain Market Revenue (USD Million), 2020-2035

US External Ventricular Drain Market YOY Growth (%), 2020-2035

US External Ventricular Drain Market Share by Regions, 2025

US External Ventricular Drain Market Player Share, 2025

US External Ventricular Drain Market Buyer Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports